Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia

We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Pede, Chiara, Congedi, Sabrina, Rossin, Sara, Divisic, Antuan, De Gregorio, Alesandra, Agosto, Caterina, Catalano, Igor, Mazza, Alessandro, Sartori, Leonardo, Masiero, Stefano, Benini, Franca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055947/
https://www.ncbi.nlm.nih.gov/pubmed/27747122
http://dx.doi.org/10.1155/2016/2329483
_version_ 1782458824029896704
author Di Pede, Chiara
Congedi, Sabrina
Rossin, Sara
Divisic, Antuan
De Gregorio, Alesandra
Agosto, Caterina
Catalano, Igor
Mazza, Alessandro
Sartori, Leonardo
Masiero, Stefano
Benini, Franca
author_facet Di Pede, Chiara
Congedi, Sabrina
Rossin, Sara
Divisic, Antuan
De Gregorio, Alesandra
Agosto, Caterina
Catalano, Igor
Mazza, Alessandro
Sartori, Leonardo
Masiero, Stefano
Benini, Franca
author_sort Di Pede, Chiara
collection PubMed
description We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD in the paediatric population.
format Online
Article
Text
id pubmed-5055947
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50559472016-10-16 Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia Di Pede, Chiara Congedi, Sabrina Rossin, Sara Divisic, Antuan De Gregorio, Alesandra Agosto, Caterina Catalano, Igor Mazza, Alessandro Sartori, Leonardo Masiero, Stefano Benini, Franca Case Rep Pediatr Case Report We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD in the paediatric population. Hindawi Publishing Corporation 2016 2016-09-22 /pmc/articles/PMC5055947/ /pubmed/27747122 http://dx.doi.org/10.1155/2016/2329483 Text en Copyright © 2016 Chiara Di Pede et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Di Pede, Chiara
Congedi, Sabrina
Rossin, Sara
Divisic, Antuan
De Gregorio, Alesandra
Agosto, Caterina
Catalano, Igor
Mazza, Alessandro
Sartori, Leonardo
Masiero, Stefano
Benini, Franca
Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
title Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
title_full Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
title_fullStr Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
title_full_unstemmed Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
title_short Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
title_sort use of zoledronic acid in paediatric craniofacial fibrous dysplasia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055947/
https://www.ncbi.nlm.nih.gov/pubmed/27747122
http://dx.doi.org/10.1155/2016/2329483
work_keys_str_mv AT dipedechiara useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT congedisabrina useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT rossinsara useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT divisicantuan useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT degregorioalesandra useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT agostocaterina useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT catalanoigor useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT mazzaalessandro useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT sartorileonardo useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT masierostefano useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia
AT beninifranca useofzoledronicacidinpaediatriccraniofacialfibrousdysplasia

Ejemplares similares